1. M. Guttman, J. Burkholder J, S.J. Kish, D. Hussey, A. Wilson, J. DaSitva, and S. Houle, [11C]RTI-32 PET studies of the dopamine transporter in early dopa-naive Parkinson’s disease: implications for the symptomatic threshold, Neurology 48, 1578–1583 (1997).
2. A. Björ klund, and O. Lindvall, Dopamine-containing systems in the CNS, in: Handbook of chemical neuroanatomy. Classical transmitters in the CNS. Part, edited by A. Björklund, and T. Hökfelt (El-sevier, Amsterdam, 1984), pp. 55–122.
3. B. Scatton, T. Dennis, R. L’Heureux, J.C. Monfort, C. Duyckaerts, and F. Javoy-Agid, Degeneration of noradrenergic and serotonergic but not dopaminergic neurones in the lumbar spinal cord of parkinsonian patients, Brain Res. 380, 181–185 (1986).
4. CD. Marsden, Neuromelanin and Parkinson’s disease. J. Neural. Transm. 19, 121–141 (1983).
5. L.S. Forno, Pathology of Parkinson’s disease: the importance of the substantia nigra and Lewy bodies, in: Parkinson’s disease, edited by G M. Stern (The Johns Hopkins University Press, Baltimore, 1990), pp. 185–238.